Identification of placental transforming growth factor-β and bikunin metabolites as contaminants of pharmaceutical human chorionic gonadotrophin preparations by proteomic techniques

Molecular and Cellular Proteomics

Volumn 4, Issue 7, 2005, Pages 984-992

  Malatos, Sotiris ^a,b   Neubert, Hendrik ^c   Kicman, Andrew T ^c   Iles, Ray K ^a,b  

^a MIDDLESEX UNIVERSITY   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; POLYPEPTIDE; PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; ULINASTATIN;

AMINO TERMINAL SEQUENCE; ARTICLE; DISSOCIATION; DRUG CONTAMINATION; GEL PERMEATION CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS; KAPOSI SARCOMA; PEPTIDE MAPPING; PLACENTA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEOMICS; TIME OF FLIGHT MASS SPECTROMETRY;

AMINO ACID SEQUENCE; CHORIONIC GONADOTROPIN; CHROMATOGRAPHY, GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HIV INFECTIONS; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PLACENTA; PROTEOMICS; SARCOMA, KAPOSI; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFORMING GROWTH FACTOR BETA; TRYPSIN INHIBITOR, KUNITZ SOYBEAN;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 24944514702     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M500085-MCP200     Document Type: Article

References (48)

1. Bourinbaiar, A. S., and Nagorny, R. (1992) Inhibitory effect of human chorionic gonadotropin (hCG) on HIV-1 transmission from lymphocytes to trophoblasts. FEBS Lett. 309, 82-84
2. Bourinbaiar, A. S., and Lee-Huang, S. (1995) Anti-HIV effect of β subunit of human chorionic gonadotropin (βhCG) in vitro. Immunol. Lett. 44, 13-18
3. McNamee, D. (1995) β-hCG inhibits Kaposi's sarcoma. Lancet 345, 1169
4. Lunardi-Iskandar, Y., Bryant, J. L., Zeman, R. A., Lam, V. H., Samaniego, F., Besnier, J. M., Hermans, P., Thierry, A. R., Gill, P., and Gallo, R. C. (1995) Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375, 64-68
5. Lang, M. E., Lottersberger, C., Roth, B., Bock, G., Recheis, H., Sgonc, R., Sturzl, M., Albini, A., Tschachler, E., Zangerle, R., Donini, S., Feichtinger, H., and Schwarz, S. (1997) Induction of apoptosis in Kaposi's sarcoma spindle cell cultures by the subunits of human chorionic gonadotropin. AIDS 11, 1333-1340
6. Butler, S. A., and Iles, R. K. (2003) Ectopic hCGβ secretion by epithelial tumors and hCGβ induced apoptosis in Kaposi's sarcoma: is there a connection? Clin. Cancer Res. 9, 4666-4673
7. Darzynkiewicz, Z. (1999) The butler did it: search for killer(s) of Kaposi's sarcoma cells in preparations of human chorionic gonadotropin. J. Natl. Cancer Inst. 91, 104-106
8. Boshoff, C., and Weiss, R. A. (2001) Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos. Trans. R. Soc. Lond. B 356, 517-534
9. Wahman, A., Melnick, S. L., Rhame, F. S., and Potter, J. D. (1991) The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma. Epidemiol. Rev. 13, 178-199
10. Berger, P., and Dimhofer, S. (1995) Kaposi's sarcoma in pregnant women. Nature 377, 21-22
11. Harris, P. J. (1995) Treatment of Kaposi's sarcoma and other manifestations of AIDS with human chorionic gonadotropin. Lancet 346, 118-119
12. Harris, P. J. (1997) Intralesional human chorionic gonadotropin for Kaposi's sarcoma. N. Engl. J. Med. 336, 1187-1189
13. Gill, P. S., Lunardi-Iskandar, Y., Louie, S., Tulpule, A., Zheng, T., Espina, B. M., Besnier, J. M., Hermans, P., Levine, A. M., Bryant, J. L., and Gallo, R. C. (1996) The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N. Engl. J. Med. 335, 1261-1269
14. Gill, P., Tsai, Y., Rao, A. P., and Jones, P. (1997) Clonality in Kaposi's sarcoma. N. Engl. J. Med. 337, 570-572
15. Gill, P. S., McLaughlin, T., Espina, P. M., Tulpule, A., Louie, S., Lunardi-Iskandar, Y., and Gallo, R. C. (1997) Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. J. Natl. Cancer Inst. 89, 1797-1802
16. Hermans, P., Clumeck, N., Picard, O., van Vooren, J. P., Duriez, P., Zucman, D., Bryant, J. L., Gill, P., Lunardi-Iskandar, Y., and Gallo, R. C. (1998) AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations. J. Hum. Virol. 1, 82-89
17. Tavio, M., Nasti, G., Simonelli, C., Vaccher, E., De Paoli, P., Giacca, M., and Tirelli, U. (1998) Human chorionic gonadotropin in the treatment of HIV-related Kaposi's sarcoma. Eur. J. Cancer 34, 1634-1637
18. Krown, S. E. (1996) Kaposi's sarcoma - what's human chorionic gonadotropin got to do with it? N. Engl. J. Med. 335, 1309-1310
19. Rabkin, C. S., Chibwe, G., Muyunda, K., and Musaba, E. (1995) Kaposi's sarcoma in pregnant women. Nature 377, 21
20. Albini, A., Paglieri, I., Crengo, G., Carlone, S., Aluigi, M. G., DeMarchi, R., Matteucci, C., Mantovani, A., Carozzi, F., Donini, S., and Benelli, R. (1997) The β-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS 11, 713-721
21. Kachra, Z., Guo, W. X., Sairam, M. R., and Antakly, T. (1997) Low molecular weight components but not dimeric hCG inhibit growth and down-regulate AP-1 transcription factor in Kaposi's sarcoma cells. Endocrinology 138, 4038-4041
22. 125I-human luteinizing hormone from Candida albicans binding sites by ribonucleases. Mol. Cell. Endocrinol. 134, 69-76
23. Griffiths, S. J., Adams, D. J., and Talbot, S. J. (1997) Ribonuclease inhibits Kaposi's sarcoma. Nature 390, 568
24. Lee-Huang, S., Huang, P. L., Sun, Y., Huang, P. L., Kung, H., Blithe, D. L., and Chen, H. (1999) Lysozyme and RNases as anti-HIV components in β-core preparations of human chorionic gonadotropin. Proc. Natl. Acad. Sci. U. S. A. 96, 2678-2681
25. Lunardi-Iskandar, Y., Bryant, J. L., Blattner, W. A., Hung, C. L., Flamand, L., Gill, P., Hermans, P., Birken, S., and Gallo, R. C. (1998) Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease. Nat. Med. 4, 428-434
26. Samaniego, F., Bryant, J. L., Liu, N., Karp, J. E., Sabichi, A. L., Thierry, A., Lunardi-Iskandar, Y., and Gallo, R. C. (1999) Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin. J. Natl. Cancer Inst. 91, 135-143
27. Lee, C. L., Iles, R. K., Shepherd, J. H., Hudson, C. N., and Chard, T. (1991) The purification and development of a radioimmunoassay for β-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women. J. Endocrinol. 130, 481-489
28. Jeno, P., Mini, T., Moes, S., Hintermann, E., and Horst, M. (1995) Internal sequences from proteins digested in polyacrylamide gels. Anal. Biochem. 224, 75-82
29. Schuerenberg, M., Luebbert, C., Eickhoff, H., Kalkum, M., Lehrach, H., and Nordhoff, E. (2000) Prestructured MALDI-MS sample supports. Anal. Chem. 72, 3436-3442
30. Fries, E., and Blom, A. M. (2000) Bikunin - not just a plasma proteinase inhibitor. Int. J. Biochem. Cell Biol. 32, 125-137
31. Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S., Pryor, K., Walsh, B. J., Nicholson, R. C., Fairlie, W. D., Por, S. B., Robbins, J. M., and Breit, S. N. (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily. Proc. Natl. Acad. Sci. U. S. A. 94, 11514-11519
32. Fairlie, W. D., Moore, A. G., Bauskin, A. R., Russell, P. K., Zhang, H. P., and Breit, S. N. (1999) MIC-1 is a novel TGF-β superfamily cytokine associated with macrophage activation. J. Leukoc. Biol. 65, 2-5
33. Moore, A. G., Brown, D. A., Fairlie, W. D., Bauskin, A. R., Brown, P. K., Munier, M. L. C., Russell, P. K., Salamonsen, L. A., Wallace, E. M., and Breit, S. N. (2000) The transforming growth factor-β superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J. Clin. Endocrinol. Metab. 85, 4781-4788
34. Li, P. X., Wong, J., Ayed, A., Ngo, D., Brade, A. M., Arrowsmith, C., Austin, R. C., and Klamut, H. J. (2000) Placental transforming growth factor-β is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J. Biol. Chem. 275, 20127-20135
35. Graichen, R., Liu, D. X., Sun, Y., Lee, K. O., and Lobie, P. E. (2002) Autocrine human growth hormone inhibits placental transforming growth factor-β gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells. J. Biol. Chem. 277, 26662-26672
36. Kakehi, Y., Segawa, T., Wu, X. X., Kulkarni, P., Dhir, R., and Getzenberg, R. H. (2004) Down-regulation of macrophage inhibitory cytokine-I/prostate derived factor in benign prostatic hyperplasia. Prostate 59, 351-356
37. Liu, T., Bauskin, A. R., Zaunders, J., Brown, D. A., Pankurst, S., Russell, P. J., and Breit, S. N. (2003) Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res. 63, 5034-5040
38. Yang, H., Filipovic, Z., Brown, D., Breit, S. N., and Vassilev, L. T. (2003) Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation. Mol. Cancer Ther. 2, 1023-1029
39. Brown, D. A., Ward, R. L., Buckhaults, P., Liu, T., Romans, K. E., Hawkins, N. J., Bauskin, A. R., Kinzler, K. W., Vogelstein, B., and Breit, S. N. (2003) MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin. Cancer Res. 9, 2642-2650
40. Lee, D. H., Yang, Y., Lee, S. J., Kim, K., Koo, T. H., Shin, S. M., Song, K. S., Lee, Y. H., Kim, Y., Lee, J. J., Choi, I., and Lee, J. (2003) Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Cancer Res. 63, 4648-4655
41. Sgadari, C., Monini, P., Barillari, G., and Ensoli, B. (2003) Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth. Lancet Oncol. 4, 537-547
42. + lymphocytes and inhibition of HIV-1 replication in H9 cells by recombinant aprotinin and bikunin homologues. J. Protein Chem. 16, 651-660
43. Hamasuna, R., Kataoka, H., Meng, J. Y., Itoh, H., Moriyama, T., Wakisaka, S., and Koono, M. (2001) Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells. Int. J. Cancer 93, 339-345
44. Suzuki, M., Kobayashi, H., Fujie, M., Nishida, T., Takigawa, M., Kanayama, N., and Terao, T. (2002) Kunitz-type protease inhibitor bikunin disrupts phorbol ester-induced oligomerization of CD44 variant isoforms containing epitope v9 and subsequently suppresses expression of urokinase-type plasminogen activator in human chondrosarcoma cells. J. Biol. Chem. 277, 8022-8032
45. Zhuo, L., Salustri, A., and Kimata, K. (2003) A physiological function of serum proteoglycan bikunin: the chondroitin sulfate moiety plays a central role. Glycoconj. J. 19, 241-247
46. Huhtala, M. L., Pesonen, K., Kalkkinen, N., and Stenman, U. H. (1982) Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer. J. Biol. Chem. 257, 13713-13716
47. Stenman, U. H. (2002) Tumor-associated trypsin inhibitor. Clin. Chem. 48, 1206-1209
48. Kolho, K. L., Huhtala, M. L., Jalanko, H., Rauramo, I., and Stenman, U. H. (1986) Pancreatic secretory trypsin inhibitor from human amniotic fluid and fetal and neonatal urine: concentrations and physicochemical characterization. Clin. Chim. Acta 156, 123-129